|
| Press Releases |
|
 |
|
| Tuesday, June 13, 2017 |
|
|
博财经《赢版块》推介周载誉归来 |
| 大中华地区专业财经传播和投资者关系顾问公司达博思传讯顾问有限公司(LBS Communications Consulting Limited)旗下博财经与内地媒体“中金在线”合作，并联同首席合作伙伴格隆汇及新浪财经于2017年6月1日假深圳金茂深圳JW 万豪酒店成功举办第二届《赢版块》系列「港股盛世投资峰会」，并为推介周掀起序幕。 more info >> |
|
|
博財經《贏版塊》推介週載譽歸來 |
| 大中華地區專業財經傳播和投資者關係顧問公司達博思傳訊顧問有限公司(LBS Communications Consulting Limited)旗下博財經與內地媒體“中金在線”合作，並聯同首席合作夥伴格隆匯及新浪財經於2017年6月1日假深圳金茂深圳JW 萬豪酒店成功舉辦第二屆《贏版塊》系列「港股盛世投資峰會」，並為推介週掀起序幕。投資峰會及推介週讓中港兩地投資者共同探索機遇，攜手邁步港股黃金年代。 more info >> |
|
|
Bo Cai Jing "Good Fortune" Roadshow Week Returned with Pride |
| Bo Cai Jing, the Investor Relations brand under Greater-China professional Financial Communications and Investor Relations Consultancy LBS Communications Consulting Limited ("LBS Communications") partnered China leading media more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
Unitree Races Toward IPO as Robot Applications Accelerate: Shoucheng Holdings Unlocks Dual-Engine Gains
Jul 29, 2025 11:30 HKT/SGT
|
|
|
宇樹衝刺IPO、機械人應用加速落地：首程控股雙輪驅動兌現紅利
Jul 29, 2025 11:30 HKT/SGT
|
|
|
宇树冲刺IPO、机器人应用加速落地：首程控股双轮驱动兑现红利
Jul 29, 2025 11:30 HKT/SGT
|
|
|
國泰君安國際連續第三年實現營運層面「碳中和」
Jul 29, 2025 11:19 HKT/SGT
|
|
|
LENVIMA(R) (lenvatinib) in Combination with Pembrolizumab and Transarterial Chemoembolization (TACE) Approved in China for the Treatment of Unresectable, Non-Metastatic Hepatocellular Carcinoma
Jul 29, 2025 9:01 JST
|
|
|
GEN 與 Sulfateq BV 公佈治療阿茲海默症及其他神經退化性疾病的候選藥物 SUL-238 的第一階段臨床試驗正面結果
Jul 29, 2025 08:00 HKT/SGT
|
|
|
GEN 与 Sulfateq BV 公布治疗阿尔茨海默病及其他神经退行性疾病的候选药物 SUL-238 的第一阶段临床试验积极结果
Jul 29, 2025 08:00 HKT/SGT
|
|
|
China Medical System (867.HK, 8A8.SG) NDA for the Improved New Drug ZUNVEYL for Alzheimer's Disease Accepted in China
Jul 29, 2025 05:00: JST
|
|
|
China Medical System (867.HK, 8A8.SG) NDA for the Improved New Drug ZUNVEYL for Alzheimer's Disease Accepted in China
Jul 29, 2025 04:00 HKT/SGT
|
|
|
HKTDC boosts Hong Kong's competitive edge in high-value services
Jul 28, 2025 23:30 HKT/SGT
|
|
|
Intelligent Tech Unlocks the Future - Connecting the World, CITIC Telecom Unveils Future-ready Solutions at WAIC 2025
Jul 28, 2025 23:16 HKT/SGT
|
|
|
Phoenitron Grants Share Options and Sets HK$75 Million Profit Target for First Three Quarters
Jul 28, 2025 23:08 HKT/SGT
|
|
|
GEN and Sulfateq BV Announce Positive Phase 1 Trial Data on Investigational Drug SUL-238 for Alzheimer's and Other Neurodegenerative Diseases
Jul 28, 2025 21:00: JST
|
|
|
GEN and Sulfateq BV Announce Positive Phase 1 Trial Data on Investigational Drug SUL-238 for Alzheimer's and Other Neurodegenerative Diseases
Jul 28, 2025 20:00 HKT/SGT
|
|
|
KKR、トプコンに対する公開買付けを開始
Jul 28, 2025 19:30: JST
|
|
|
|
|
More News >> |
|
|
|
|
|
